Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 21299462)

Published in Leuk Lymphoma on February 08, 2011

Authors

Maciej Machaczka1, Johan Vaktnäs, Monika Klimkowska, Hans Hägglund

Author Affiliations

1: Hematology Center Karolinska, Karolinska University Hospital Huddinge, Stockholm, Sweden. maciej.machaczka@ki.se

Articles citing this

Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med (2014) 1.60

Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther (2012) 1.55

Hemophagocytic syndrome in children and adults. Arch Immunol Ther Exp (Warsz) (2014) 1.05

Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis (2015) 0.90

Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica (2015) 0.90

Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes. Cancer (2016) 0.83

Haemophagocytic lymphohistiocytosis presenting as liver failure following Epstein-Barr and prior hepatitis A infections. BMJ Case Rep (2013) 0.81

The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis. Dis Markers (2016) 0.79

Secondary haemophagocytic lymphohistiocytosis: Experience from the Uppsala University Hospital. Ups J Med Sci (2015) 0.79

Hemophagocytic lymphohistiocytosis as a paraneoplastic syndrome associated with ovarian dysgerminoma. Gynecol Oncol Rep (2016) 0.75

Hemophagocytic lymphohistiocytosis in adults. Ups J Med Sci (2013) 0.75

Hemophagocytic Lymphohistiocytosis in a Patient with Classical Hodgkin Lymphoma. Case Rep Hematol (2016) 0.75

A retrospective analysis of 56 children with hemophagocytic lymphohistiocytosis. J Blood Med (2016) 0.75

Hemophagocyte lymphohistiocytosis secondary to bilateral epididymal diffuse large B-cell lymphoma. Indian J Hematol Blood Transfus (2013) 0.75

Hemophagocytic lymphohistiocytosis in adults: An under recognized entity. BBA Clin (2016) 0.75

Hemophagocytic Lymphohistiocytosis in a Patient With Hodgkin lymphoma and Concurrent EBV, CMV, and Candida Infections. J Investig Med High Impact Case Rep (2017) 0.75

A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions. Oncotarget (2017) 0.75

A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer (2017) 0.75

Articles by these authors

Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections. Arthritis Rheum (2011) 2.06

Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol Blood Marrow Transplant (2011) 1.90

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood (2002) 1.55

Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant (2011) 1.54

Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia? Leuk Lymphoma (2009) 1.41

[Future care requires future ways of working]. Lakartidningen (2009) 1.39

Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood (2012) 1.23

Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant (2009) 1.15

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006. Cancer (2011) 0.99

Gaucher disease with foamy transformed macrophages and erythrophagocytic activity. J Inherit Metab Dis (2010) 0.98

Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biol Blood Marrow Transplant (2003) 0.98

Atypical cytomorphology of Gaucher cells is frequently seen in bone marrow smears from untreated patients with Gaucher disease type 1. Folia Histochem Cytobiol (2015) 0.96

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis. Med Oncol (2008) 0.95

Treatment of multiple myeloma in patients with Gaucher disease. Am J Hematol (2009) 0.94

Portal vein thrombosis is a common complication following splenectomy in patients with malignant haematological diseases. Eur J Haematol (2006) 0.91

A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors. Clin Transplant (2013) 0.90

Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation. Med Oncol (2011) 0.87

Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution. Ups J Med Sci (2012) 0.86

High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007. Haematologica (2012) 0.85

Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1. Pol Arch Med Wewn (2014) 0.85

Up-regulated estrogen receptor β2 in chronic lymphocytic leukemia. Leuk Lymphoma (2011) 0.83

Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia. Br J Haematol (2007) 0.81

Development of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutations. Haematologica (2012) 0.81

Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use? Med Oncol (2007) 0.81

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. Wien Klin Wochenschr (2012) 0.80

Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cells. Stem Cells Dev (2012) 0.80

Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma. Med Oncol (2010) 0.80

Recurrent pulmonary aspergillosis and mycobacterial infection in an unsplenectomized patient with type 1 Gaucher disease. Ups J Med Sci (2013) 0.80

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden. Eur J Haematol (2014) 0.79

Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival? Leuk Lymphoma (2012) 0.78

An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients. Haematologica (2008) 0.78

Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3. Arch Immunol Ther Exp (Warsz) (2014) 0.78

Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1. Ann Hematol (2014) 0.77

Alemtuzumab treatment for hemophagocytic lymphohistiocytosis. Nat Rev Clin Oncol (2010) 0.77

Bone marrow derived cells in adult skeletal muscle tissue in humans. Skelet Muscle (2013) 0.77

Microvascular density in chronic pancreatitis and pancreatic ductal adenocarcinoma. Folia Histochem Cytobiol (2003) 0.77

Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden. Leuk Lymphoma (2010) 0.76

Posttransplant lymphoma--a single-center experience of 500 liver transplantations. Med Oncol (2004) 0.76

The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation. Clin Transl Allergy (2013) 0.75

Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results. Med Oncol (2011) 0.75

High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse. Med Oncol (2013) 0.75

[A case report. Oral swelling and skin rash were not an allergic reaction]. Lakartidningen (2002) 0.75

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study. Med Oncol (2015) 0.75

Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study. Leuk Lymphoma (2011) 0.75

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome. Stem Cells Transl Med (2016) 0.75

Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts. Med Oncol (2011) 0.75

Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study. Am J Hematol (2011) 0.75

Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus. Acta Derm Venereol (2016) 0.75

[Systemic mastocytosis. Underestimated condition in patients with idiopathic anaphylaxis]. Lakartidningen (2012) 0.75

Oral lesions in the course of myelofibrosis successfully treated using combination therapy with thalidomide, betamethasone, and cytarabine. Pol Arch Med Wewn (2013) 0.75

Multiple skin lesions caused by imatinib mesylate treatment of chronic myeloid leukemia. Pol Arch Med Wewn (2013) 0.75